![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 32, 30435-30441, August 10, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
¶
From the
Department of Biochemistry and
Montréal Joint Center for Structural Biology, McIntyre Medical
Sciences Building, McGill University, Montréal, Québec H3G
1Y6, Canada, Fachbereich Biologe, University of Konstanz, D-78457
Konstanz, Germany, and ¶ Departments of Biology and
Chemistry, Sinsheimer Laboratory, University of California Santa Cruz,
Santa Cruz, California 95064
Received for publication, May 7, 2001, and in revised form, June 6, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Cholesterol oxidase is a monomeric flavoenzyme
that catalyzes the oxidation and isomerization of cholesterol to
cholest-4-en-3-one. Two forms of the enzyme are known, one containing
the cofactor non-covalently bound to the protein and one in which the
cofactor is covalently linked to a histidine residue. The x-ray
structure of the enzyme from Brevibacterium sterolicum
containing covalently bound FAD has been determined and refined to
1.7-Å resolution. The active site consists of a cavity sealed off from
the exterior of the protein. A model for the steroid substrate,
cholesterol, can be positioned in the pocket revealing the structural
factors that result in different substrate binding affinities between the two known forms of the enzyme. The structure suggests that Glu475, located at the active site cavity, may act as the
base for both the oxidation and the isomerization steps of the
catalytic reaction. A water-filled channel extending toward the flavin
moiety, inside the substrate-binding cavity, may act as the entry point
for molecular oxygen for the oxidative half-reaction. An arginine and a
glutamate residue at the active site, found in two conformations are
proposed to control oxygen access to the cavity from the channel. These concerted side chain movements provide an explanation for the biphasic
mode of reaction with dioxygen and the ping-pong kinetic mechanism
exhibited by the enzyme.
Cholesterol oxidase is a flavoprotein that catalyzes the oxidation
and isomerization of steroids containing a 3
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-hydroxyl group and a
double bond at C-5 of the steroid ring system (see Scheme
1). The enzyme has been used in the
determination of serum cholesterol and in the clinical diagnosis of
arteriosclerosis and other lipid disorders. In addition, it has been
shown to be a potent larvicide (1-3) and is currently being developed
in the agricultural industry as a pest control (4). Furthermore, cholesterol oxidase is an example of a soluble enzyme that interacts with a lipid bilayer to bind an insoluble substrate. Structural and
biochemical studies on the enzyme containing the flavin adenine dinucleotide (FAD)1 cofactor
non-covalently bound to the protein have revealed the region of the
enzyme involved in interaction with the lipid bilayer and have led to a
possible mechanism for membrane interaction (5-7).

View larger version (8K):
[in a new window]
Scheme 1.
In Brevibacterium sterolicum, cholesterol oxidase has been found to exist in two forms, one in which the FAD cofactor is non-covalently bound to the enzyme (BCO1) and one in which the cofactor is covalently linked (BCO2). Although these enzymes share the same catalytic activity they show no sequence homology. Comparisons of these two forms of cholesterol oxidase reveal large differences in redox potential and kinetic properties suggesting different mechanisms (8). These studies support the hypothesis that there are significant structural differences between the two enzyme forms, correlated with changes in biochemical properties.
Here we report the structure of BCO2 refined to 1.7-Å resolution. The
structure reveals features of the enzyme that support previously
proposed models of both substrate binding and catalysis. Furthermore,
specific active site residues can now be implicated in the mechanisms
for oxidation, isomerization, and for the oxidative half-reaction of
the enzyme.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Data Collection and Processing--
Pure recombinant BCO2 was
obtained from Roche Molecular Diagnostics. Crystals were grown by vapor
diffusion as described previously (9). The crystals belong to space
group P21 with unit cell dimension a = 77.44 Å,
b = 124.47 Å, c = 80.84 Å, and
= 109.2° and contain 2 molecules in the asymmetric unit.
Prior to data collection the crystals were briefly soaked in a
cryoprotectant solution containing 20% ethanediol. Data for the low
resolution native crystal and the mercurial derivatives were collected
on a MAR image plate detector with a double focussing mirror system (Supper, Ltd.) mounted on a Rigaku RU-200 rotating anode x-ray generator. The high-resolution native data were collected at 0.979 Å on beamline X8-C (NSLS, Brookhaven National Laboratory, New York). The
x-ray images were processed using the HKL suite of software (10, 11).
Table I
gives the data collection and processing statistics.
|
|
Phase Determination and Refinement--
The structure was solved
by the method of single isomorphous replacement using a mercurial
derivative (HgCl2). Two different soak concentrations of
the heavy atom solution were used giving slightly different phase
information (see Tables I and II). Heavy atom refinement was carried
out using the program MLPHARE. The initial phases from heavy atom
refinement of two mercurial sites were significantly improved by
solvent flipping using SOLOMON (12). A partial model was built for each
protomer in the asymmetric unit and used to determine the
non-crystallographic symmetry matrices. The program DM was used to
further improve the phases by 2-fold averaging, solvent flattening, and
histogram matching. The improved quality of the electron density map
enabled a more complete model to be built. The model phases were
gradually combined with the MIR phases using SIGMAA and the resulting
maps used to complete building of the model. Model building was
performed with O (13) and refinement carried out with CNS (14) using
the high-resolution data (Native 2). Each cycle of refinement was
followed by a manual rebuild using the program O. SIGMAA weighted maps
calculated with coefficients 3Fo
2Fc and Fo
Fc were used for the model rebuilds. In the final
stages of refinement 2Fo
Fc
maps were used. Water molecules were built where difference electron
density above 3
was observed and where hydrogen bond contacts were
made to other polar atoms. As the refinement neared completion,
difference electron density maps indicated the presence of 12 molecules
of ethanediol, 3 Mn2+ ions, and 1 cacodylate molecule. In
the final stages of refinement the NCS constraints were removed and
multiple conformations for the side chains of 46 residues as well as
one ethanediol molecule located in the active site were included. A
surface exposed loop in each protomer was not included in the final
model since the density was not sufficiently well defined.
Superposition of identical
-carbon positions for the two molecules
results in an r.m.s. difference of 0.27 Å indicating that the two
subunits are structurally identical. The Ramachandran plot indicates
that all residues lie in allowed regions of
/
space (15). The
final refinement statistics are given in Table II. The atomic
coordinates and structure factors have been deposited in the Brookhaven
Protein Data Bank (16) (accession codes 1I19).
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Overall Structure-- Cholesterol oxidase (BCO2) from B. sterolicum containing FAD covalently attached to the protein is a monomeric enzyme of 613 amino acid residues. The full-length enzyme contains a hydrophobic presequence of 52 residues, the function of which is currently not known. The protein is cleaved after residue 52 to give the 62-kDa mature form of the enzyme. The structure for the mature enzyme has been determined by the method of single isomorphous replacement and refined to 1.7-Å resolution.
The structure is composed of 12
-helices and 17
-strands and can
be subdivided into two functionally distinct domains: an FAD-binding
domain and a substrate-binding domain (Fig.
1). Although BCO2 carries out an
identical catalytic reaction to that of BCO1, the structural folds for
the two enzymes are vastly different. In particular, the nucleotide
binding fold commonly seen in the FAD-binding domain is not present in
BCO2; rather it adopts a fold seen in the structures of vanillyl
alcohol oxidase (VAO) (17), murB (18), the molybdenum-containing enzyme
carbon monoxide dehydrogenase (19), and p-cresol
methylhydroxylase (20). This fold has recently been described as a new
family of structurally related oxidoreductases (21). The r.m.s.
deviation for 140
-carbon atoms within the FAD-binding domain
between VAO and BCO2 is 1.7 Å. Although BCO2 was not originally
included in this family of enzymes due to the lack of sequence
homology, the observed structure homology indicates that it is also a
member of this new oxidoreductase family.
|
The substrate-binding domain (residues 275-565) is
comprised of an 8-stranded mixed
-pleated sheet and 6
-helices.
This domain is positioned over the isoalloxazine ring system of the FAD
cofactor and forms the roof of the active site cavity. The motif for
this domain is also observed in the structures of VAO and
p-cresol methylhydroxylase although there is no significant sequence homology between these enzymes and BCO2. Superposition of 94
-carbon atoms within the substrate-binding domains of BCO2 and VAO
results in an r.m.s. deviation of 2.1 Å.
FAD Binding-- The FAD is deeply buried in the protein structure and is involved in extensive contacts mainly with the FAD-binding domain. The pyrophosphate group is involved in hydrogen bond contacts with main chain atoms of the loop between Gly118 and Gly122. A similar type of interaction has also been observed in the structure of VAO and this loop region has been defined as the PP loop (17).
The cofactor is linked to the protein through a covalent bond between
ND1 of the imidazole side chain of His121 (a residue in the
PP loop) and the 8-methyl group of the isoalloxazine ring (Fig.
2). The histidine side chain approaches
the isoalloxazine ring from the si face of the flavin unlike
VAO where the covalent histidine originates in the
substrate-binding domain and approaches the flavin moiety from the
re face. Therefore, in BCO2, the PP loop appears to play a
critical role in positioning the cofactor correctly within the
structure of the enzyme through two factors: the covalent linkage to
the isoalloxazine ring and the hydrogen bond interactions with the
pyrophosphate moiety.
|
A number of flavoenzymes have been found to contain a covalent linkage between the cofactor and the protein (reviewed by Mewies et al (22)). The structures of covalently modified flavoenzymes that have been determined include VAO (17), where the covalent linkage is through ND2 of a histidine residue and p-cresol methylhydroxylase (20) where the linkage is through a tyrosine residue. BCO2 represents the first structure within this family where the protein-flavin linkage is through the ND1 atom of a histidine residue and from the re face of the isoalloxazine ring system.
Active Site--
The active site of BCO2 consists of a cavity
(with a volume of 450 Å3) bounded on one side by the
-pleated sheet in the substrate-binding domain and, on the opposite
side, by the isoalloxazine ring of the cofactor. Two loops in the
substrate-binding domain (between
12 and
5 and between
7 and
14) exhibit higher than average temperature factors suggesting a
possible entrance for cholesterol to the active site (Fig.
3a). The residues lining the
cavity near the pyrimidine moiety of the cofactor are highly
hydrophilic and include Arg477, Glu475,
Glu551, Glu432, Glu311,
Asn516, and Lys554 (Fig. 3b). The
charged nature of this region of the active site is in sharp contrast
to that seen in the structure of BCO1 and it is precisely these
differences that are likely to play an important role in the reactivity
of the flavin cofactor. The region near to the dimethylbenzene ring of
the cofactor consists mainly of hydrophobic residues. An extension away
from the main cavity and lined by hydrophobic residues is also
observed.
|
Three side chains in the active site: Arg477,
Glu475, and Ile423 adopt two distinct
conformations (Fig. 4). Their movements
appear to be coordinated with each other and with alternate positions of two water molecules and one ethanediol in the active site. In one
conformation, the guanidinium group of Arg477 is within
hydrogen bonding distance from O-4 of the isoalloxazine ring and the
hydroxyl O-2 of ethanediol (Fig. 4b). The second hydroxyl
group of ethanediol, O-1, makes contact with N-5 of FAD, and the side
chain of Ile423 is directed away from the active site
cavity. In the second conformation, the side chain of
Arg477 has swung away from the cofactor and contacts the
carboxylate group of Glu475 which has also moved away to
accommodate the arginine side chain (Fig. 4a). Two water
molecules occupy the original position of Arg477 near O-4
of the cofactor. Furthermore, the ethanediol molecule has adopted an
alternate conformation such that O-2 interacts with one of the new
water molecule positions and O-1 interacts with the newly positioned
Arg477. This alternate conformation of ethanediol results
in a repositioning of side chain of Ile423, toward the
active site cavity.
|
Oxygen Channel--
When
Glu475/Arg477/Ile432 adopts the
second conformation away from O-4 of the cofactor, a narrow channel
extends from the bulk solvent to the substrate cavity and the
isoalloxazine ring of the cofactor (Fig. 4c). This channel,
positioned between
11 of the substrate-binding domain and the loop
between
3 and
7 from the FAD-binding domain, is lined
predominantly by hydrophobic side chains and is filled with a chain of
7 water molecules connected to each other through hydrogen bonds. In
contrast, when Glu475/Arg477/Ile432
adopt the first conformation the water filled channel is sealed off
from the substrate cavity and the cofactor (Fig. 4d).
Both the location and the hydrophobic nature of this channel suggest that it may serve as an entrance for molecular oxygen to the active site during the oxidative half-reaction. A hydrophobic channel has also been observed in the structures of cytochrome c oxidase (23-25) and the role of this channel as the oxygen pathway into the heme-copper site for O-2 reduction has been further supported by mutagenesis and kinetic studies (26). However, in flavoenzyme oxidases, where molecular oxygen is used to reoxidize the reduced flavin, such an oxygen channel has not previously been observed. In the structure of BCO2, control of oxygen access would be modulated by the position of Arg477 which acts as a "gate" adopting an open conformation (Fig. 4, a and c) or a closed conformation (Fig. 4, b and d). Thus the side chain of Arg477 appears to control the entrance of oxygen to the active site in order for the oxidative half-reaction to proceed. The structure further suggests that the position of the gate may be controlled by the presence or absence of the steroid substrate.
It has recently been noted that the reaction of reduced BCO2 with dioxygen exhibits a peculiar behavior different from that of other flavoprotein oxidases (8). Specifically, the reaction of free, reduced BCO2 with molecular oxygen is biphasic; the first phase is fast and sensitive to oxygen concentration and the second phase is slower and insensitive to oxygen concentration. This behavior was proposed to reflect a reversible conversion of two species having substantially different oxygen reactivity. The alternate positions of the side chain of Arg477 and the role of this residue in gating oxygen access provides a rationale for the observed kinetic behavior. The fast phase may reflect the reaction of oxygen with the reduced cofactor through the channel in the "gate open" conformation. The slow phase would then correspond to the case in which oxygen access to the reduced flavin and reaction has to await a rate-limiting conformational change resulting in the opening of the gate. Clearly further mutagenesis and kinetic analysis would need to be carried out in order to confirm the role of Arg477 in controlling access of oxygen to the reduced flavin.
Steroid Bound Model-- Kinetic comparisons of the two forms of cholesterol oxidase (BCO1 and BCO2) reveal significant differences in cholesterol binding (8). The structural differences observed between these two enzyme forms can be correlated to these observed kinetic differences. In the structures of the BCO1 (27-29) the substrate-binding site consists of a cavity, situated on the re face of the isoalloxazine ring, that houses only the four-ring system of cholesterol. The terpene chain extending from C-17 of the steroid D ring is not accommodated in the buried pocket; rather it is presumed to interact with a series of hydrophobic loops at the surface of the molecule. The structure of BCO2 also contains a large cavity that houses the four-ring system of the steroid substrate (Fig. 3a). However, a further extension from this cavity is of the appropriate size and dimension to bind the terpene portion of the substrate (the volume of cholesterol is 327 Å3 based on van der Waals surface). Moreover, the hydrophobic nature of this extension makes it ideal for van der Waals interactions with the terpene moiety.
A model of the cholesterol bound complex is shown in Fig. 3c and clearly reveals the terpene-binding site. The interactions between the terpene moiety and the residues lining the extension can be correlated with a 10-fold increase in binding affinity observed for cholesterol in the case of the covalent form of the enzyme as compared with the non-covalent form (8). Comparisons of binding affinities of other steroid substrates that do not have a hydrophobic extension at C-17 of the steroid nucleus reveal significantly lower Km values than that observed for cholesterol. Interestingly these steroids bind to the non-covalent form of the enzyme with higher affinities than to the covalent enzyme.
Further analysis of the modeled cholesterol-bound complex reveals that
the best fit occurs when the arginine is in the "gate closed"
conformation. This places C-3 and the hydroxyl group of the steroid
substrate near to N-5 and O-4, respectively, of the cofactor.
Furthermore, the steroid hydroxyl group is within hydrogen bonding
distance from the guanidinium side chain of Arg477. In the
dehydrogenation reaction, a hydride is transferred from C-3 of the
steroid substrate to N-5 of the cofactor resulting in the anionic form
of reduced flavin, FADH
. The gate closed
conformation places the arginine side chain in a position where it can
stabilize the negative charge on the pyrimidine moiety of the cofactor.
In addition, concomitant with hydride transfer, a proton is abstracted
from the C3-OH of the steroid. In the gate closed conformation, the
carboxylate side chain of Glu475 lies 3.3 Å from the
modeled steroid C3-OH suggesting it may function as the base for proton
abstraction. Since Glu475 is also the proposed base for the
isomerization step (see below), the proton abstracted during oxidation
must be shuttled to another active site residue. The likely candidate
for this proton shuttle would be Glu311, which lies 2.6 Å from Glu475 (Fig. 4a) and is held in position by
interactions with Tyr422 and Lys324.
Furthermore, Glu311 lies near to the gated entrance for
molecular oxygen. In the gate open conformation, the carboxylate of
Glu311 hydrogen bonds to the guanidinium side chain of
Arg477 (Fig. 4b) suggesting that, upon opening
of the gate, the Arg477-Glu311 interaction may
facilitate proton transfer to the incoming oxygen molecule during the
oxidative half-reaction.
In addition to oxidation, cholesterol oxidase also carries out an
isomerization reaction, shifting the double bond from
5
to
4 of the steroid intermediate. In BCO1 structural (6,
29) and mutagenesis and kinetic studies (30) have indicated that a
single glutamate residue (Glu361) functions as the
acid/base in proton abstraction from C-4 and reprotonation at C-6 of
the steroid. The steroid bound model for BCO2 also reveals a glutamate
(Glu475) near to the isomerization center. The position of
Glu475 and the alternate conformations observed suggest
that it may function in an identical fashion to Glu361 in
BCO1. In the gate closed conformation, the carboxylate moiety of
Glu475 lies near to C-4 of the steroid A ring, well
positioned for proton abstraction. Upon rearrangement of the Arg-Glu
pair to the gate open conformation the glutamate carboxylate moves
closer to C-6 where reprotonation would occur. In addition, the gate
open conformation of Glu475 results in an unfavorable
interaction with the C-19 methyl group of the steroid, thus
destabilizing the binding of the steroid and promoting product release.
Finally, the release of the product and the opening of the gate would
enable the binding of oxygen in proximity to C4a of the cofactor where
reduction to peroxide is known to occur. Such a sequence of events is
consistent with the observed ping-pong mechanism for BCO2 (8).
In conclusion, the structure of BCO2 adopts a different fold from that
seen for BCO1. These differences reveal a number of novel features that
can be correlated with observed differences in kinetic features between
the two enzyme forms. In particular, the structure of BCO2 reveals a
substrate-binding site that is able to house an entire cholesterol
molecule including the terpene moiety. Furthermore, this structure
supports kinetic data used to propose a mechanism for BCO2 catalysis
and identifies specific residues important for each of the catalytic
events. The structure provides us with a unique view of how molecular
oxygen may access the active site of a flavoenzyme and how side chain
mobility may control this access during the oxidative
half-reaction.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Roche Diagnostics for the generous supply of BCO2. We also thank B. Ahvazi for technical assistance and P. Pawelek and P. Lario for helpful discussion.
| |
FOOTNOTES |
|---|
* This work was supported by Canadian Institutes of Health Research Grant MT13341 (to A. V.), National Institutes of Health Grant GM60535 (to A. V.), and a chercheur-boursier salary support award from the Fonds de la recherche en santé du Québec (to A. V.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biology,
Sinsheimer Lab., University of California Santa Cruz, 1156 High St.,
Santa Cruz, CA 95064. Tel.: 831-459-3929; Fax: 831-459-3139; E-mail:
vrielink@biology.ucsc.edu.
Published, JBC Papers in Press, June 7, 2001, DOI 10.1074/jbc.M104103200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FAD, flavin adenine dinucleotide; VAO, vanillyl alcohol oxidase; r.m.s., root mean square.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Corbin, D. R., Greenplate, J. T., Wong, E. Y., and Purcell, J. P. (1994) Appl. Environ. Microbiol. 60, 4239-4244 |
| 2. | Greenplate, J. T., Duck, N. B., Pershing, J. C., and Purcell, J. P. (1995) Entomol. Exp. Appl. 74, 253-258 |
| 3. | Purcell, J. P., Greenplate, J. T., Jennings, M. G., Ryerse, J. S., Pershing, J. C., Sims, S. R., Prinsen, M. J., Corbin, D. R., Tran, M., Sammons, R. D., and Stonard, R. J. (1993) Biochem. Biophys. Res. Commun. 196, 1406-1413 |
| 4. | Corbin, D. R., Greenplate, J. T., and Purcell, J. P. (1998) Hortscience 33, 614-617 |
| 5. | Ghoshroy, K. B., Zhu, W., and Sampson, N. S. (1997) Biochemistry 36, 6133-6140 |
| 6. | Li, J., Vrielink, A., Brick, P., and Blow, D. M. (1993) Biochemistry 32, 11507-11515 |
| 7. | Sampson, N. S., Kass, I. J., and Ghoshroy, K. B. (1998) Biochemistry 37, 5770-5778 |
| 8. | Pollegioni, L., Wels, G., Pilone, M. S., and Ghisla, S. (1999) Eur. J. Biochem. 263, 1-13 |
| 9. | Croteau, N., and Vrielink, A. (1996) J. Struct. Biol. 116, 317-319 |
| 10. | Otwinowski, Z., and Minor, W. (1997) in Methods in Enzymology (Carter, C. W., Jr. , and Sweet, R. M., eds) , pp. 307-326, Academic Press, London |
| 11. | Otwinowski, Z. (1993) in Data collection and Processing: Proceedings of the CCP4 Study Weekend (Sawyer, L. , Isaccs, N. , and Bailey, S., eds) , pp. 56-62, SERC Daresbury Laboratory, Warrington, United Kingdom |
| 12. | Abrahams, J. P., and Leslie, A. G. W. (1996) Acta Crystallogr. Sect. D 52, 30-42 |
| 13. | Jones, T. A., Zou, J.-Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110-119 |
| 14. | Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warrem, G. L. (1998) Acta Crystallogr. Sect. D 54, 905-921 |
| 15. | Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. App. Crystallogr. 26, 283-291 |
| 16. | Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000) Nucleic Acids Res. 28, 235-242 |
| 17. | Mattevi, A., Fraaije, M. W., Mozzarelli, A., Olivi, L., Coda, A., and van Berkel, W. J. H. (1997) Structure 5, 907-920 |
| 18. | Benson, T. E., Filman, D. J., Walsh, C. T., and Hogle, J. M. (1995) Nat. Struct. Biol. 2, 644-653 |
| 19. | Dobbek, H., Gremer, L., Meyer, O., and Huber, R. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 8884-8889 |
| 20. | Mathews, F. S., Chen, Z.-W., and Bellamy, H. D. (1991) Biochemistry 30, 238-247 |
| 21. | Fraaije, M. W., van Berkel, W. J. H., Benen, J. A. E., Visser, J., and Mattevi, A. (1998) Trends Biochem. Sci. 23, 206-207 |
| 22. | Mewies, M., McIntire, W. S., and Scrutton, N. S. (1998) Protein Sci. 7, 7-20 |
| 23. | Iwata, S., Ostermeier, C., Ludwig, B., and Michel, H. (1995) Nature 376, 660-669 |
| 24. | Riistama, S., Puustinen, A., Garciahorsman, A., Iwata, S., Michel, H., and Wikstrom, M. (1996) Biochim. Biophys. Acta Bioenerg. 1275, 1-4 |
| 25. | Soulimane, T., Buse, G., Bourenkov, G. P., Bartunik, H. D., Huber, R., and Than, M. E. (2000) EMBO J. 19, 1766-1776 |
| 26. | Riistama, S., Puustinen, A., Verkhovsky, M. I., Morgan, J. E., and Wikstrom, M. (2000) Biochemistry 39, 6365-6372 |
| 27. | Vrielink, A., Lloyd, L. F., and Blow, D. M. (1991) J. Mol. Biol. 219, 533-554 |
| 28. | Vrielink, A., Li, J., Brick, P., and Blow, D. M. (1994) in Flavins and Flavoproteins (Curti, B. , Ronchi, S. , and Zanetti, G., eds) , pp. 175-184, Water de Gruyter & Co., Berlin |
| 29. | Yue, Q. K., Kass, I. J., Sampson, N. S., and Vrielink, A. (1999) Biochemistry 38, 4277-4286 |
| 30. | Kass, I. J., and Sampson, N. S. (1998) Bioorg. Medi. Chem. Lett. 8, 2663-2668 |
| 31. | Kraulis, P. (1991) J. Appl. Crystallogr. 24, 946-950 |
| 32. | Nicholls, A., Sharp, K., and Honig, B. (1991) Proteins 11, 281-296 |
This article has been cited by other articles:
![]() |
A. Y. Lyubimov, K. Heard, H. Tang, N. S. Sampson, and A. Vrielink Distortion of flavin geometry is linked to ligand binding in cholesterol oxidase Protein Sci., December 1, 2007; 16(12): 2647 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Saam, I. Ivanov, M. Walther, H.-G. Holzhutter, and H. Kuhn Molecular dioxygen enters the active site of 12/15-lipoxygenase via dynamic oxygen access channels PNAS, August 14, 2007; 104(33): 13319 - 13324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saito, M. Kanno, H. Iizuka, and H. Suzuki Kinetic Studies on the Role of Lys-171 and Lys-358 in the {beta} Subunit of Sarcosine Oxidase from Corynebacterium sp. U-96 J. Biochem., June 1, 2007; 141(6): 799 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Caldinelli, S. Iametti, A. Barbiroli, F. Bonomi, D. Fessas, G. Molla, M. S. Pilone, and L. Pollegioni Dissecting the Structural Determinants of the Stability of Cholesterol Oxidase Containing Covalently Bound Flavin J. Biol. Chem., June 17, 2005; 280(24): 22572 - 22581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Phillips, F. G. Whitby, C. A. Warby, P. Labbe, C. Yang, J. W. Pflugrath, J. D. Ferrara, H. Robinson, J. P. Kushner, and C. P. Hill Crystal Structure of the Oxygen-dependant Coproporphyrinogen Oxidase (Hem13p) of Saccharomyces cerevisiae J. Biol. Chem., September 10, 2004; 279(37): 38960 - 38968. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Thompson, K. Katayama, K. Watanabe, C. R. Hutchinson, and I. Rayment Structural and Functional Analysis of Tetracenomycin F2 Cyclase from Streptomyces glaucescens: A TYPE II POLYKETIDE CYCLASE J. Biol. Chem., September 3, 2004; 279(36): 37956 - 37963. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Brufatto and M. E. Nesheim Analysis of the Kinetics of Prothrombin Activation and Evidence That Two Equilibrating Forms of Prothrombinase Are Involved in the Process J. Biol. Chem., February 21, 2003; 278(9): 6755 - 6764. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |